Utility of Post-Procedural HFA-PEFF Reassessment for Long-Term Heart Failure Risk Stratification After Atrial

Hironori Ishiguchi1, Yasuhiro Yoshiga1, Masakazu Fukuda1

  • 1Division of Cardiology, Department of Medicine and Clinical Science Yamaguchi University Graduate School of Medicine Ube Japan.

Journal of Arrhythmia
|July 13, 2026
PubMed

Insights

Post-procedural Heart Failure Audit-Performance, Evaluation, and Follow-up (HFA-PEFF) scores improve long-term heart failure risk prediction after atrial fibrillation ablation. This reassessment is especially valuable for patients with high baseline HFA-PEFF scores.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • The role of post-procedural Heart Failure Audit-Performance, Evaluation, and Follow-up (HFA-PEFF) scoring for long-term heart failure (HF) risk stratification following atrial fibrillation (AF) ablation is not well-established.
  • Atrial fibrillation ablation is a common procedure, and optimizing risk stratification for HF post-ablation is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the utility of pre-procedural and post-procedural HFA-PEFF scores in predicting long-term HF hospitalization after AF ablation in patients with preserved ejection fraction.
  • To compare the risk stratification performance of post-procedural HFA-PEFF reassessment against pre-procedural scores.

Main Methods:

  • A retrospective cohort study involving 856 patients with preserved left ventricular ejection fraction (≥50%) undergoing AF ablation.
  • HFA-PEFF scores were assessed before and after ablation (median 91 days post-ablation).
  • HF hospitalization rates were compared across risk strata (low, intermediate, high) for both scores, with discrimination assessed using time-dependent ROC analysis at 2-5 years.

Main Results:

  • The HFA-PEFF score significantly decreased post-ablation (median 3 to 2, p < 0.001), primarily due to changes in biomarkers.
  • Post-procedural HFA-PEFF demonstrated superior discrimination for HF hospitalization compared to the pre-procedural score, particularly at 5 years (AUC 0.791 vs 0.686).
  • Improved discrimination was noted in high-risk patients when assessing changes in HFA-PEFF scores.

Conclusions:

  • Post-procedural HFA-PEFF reassessment offers added value for long-term HF hospitalization risk stratification in patients with preserved ejection fraction undergoing AF ablation.
  • The benefit of reassessment is particularly pronounced in patients identified as high-risk by their baseline HFA-PEFF scores.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...